Evidence map›Paper›PMID 31502538›Full record

ArticleeLife2019

The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats.

Paolo Campus, Ignacio R Covelo, Youngsoo Kim, Aram Parsegian, Brittany N Kuhn, Sofia A Lopez, John F Neumaier, Susan M Ferguson, Leah C Solberg Woods, Martin Sarter and 1 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Administration of an extrasynaptic δ-subunit GABAJournal of psychopharmacology (Oxford, England) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paolo Campus *Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, United States.ORCID 0000-0002-6513-6158
Ignacio R Covelo *Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, United States.ORCID 0000-0003-2469-2454
Youngsoo KimDepartment of Psychology, University of Michigan, Ann Arbor, United States.
Aram ParsegianMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, United States.
Brittany N KuhnNeuroscience Graduate Program, University of Michigan, Ann Arbor, United States.
Sofia A LopezNeuroscience Graduate Program, University of Michigan, Ann Arbor, United States.
John F NeumaierDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, United States.
Susan M FergusonDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, United States.
Leah C Solberg WoodsDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, United States.
Martin SarterDepartment of Psychology, University of Michigan, Ann Arbor, United States.
Shelly B FlagelMolecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, United States.ORCID 0000-0002-7309-9908

Funding

POSTDOCTORAL TRAINING IN THE BIOLOGY OF DRUG ABUSET32DA007268 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1991 to 2021
$6.7M
NIDA Training Program in Neuroscience-Administrative SupplementT32DA007281 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shelly Beth Flagel · 1995 to 2026
$5.7M
Dynamic control of cue-driven behavior via the paraventricular thalamic nucleusR01DA038599 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FLAGEL, SHELLY BETH · 2015 to 2019
$2.7M
Addiction liability, poor attentional control, and cholinergic deficiencyR01DA045063 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTER, MARTIN F · 2018 to 2022
$1.9M
NIDA NIH HHS R01 DA038599NIDA NIH HHS R01-DA038599NIDA NIH HHS T32 DA007268NIDA NIH HHS T32-DA007268NIDA NIH HHS T32-DA007821
6 · The paper itself

Abstract

Cues in the environment can elicit complex emotional states, and thereby maladaptive behavior, as a function of their ascribed value. Here we capture individual variation in the propensity to attribute motivational value to reward-cues using the sign-tracker/goal-tracker animal model. Goal-trackers attribute predictive value to reward-cues, and sign-trackers attribute both predictive and incentive value. Using chemogenetics and microdialysis, we show that, in sign-trackers, stimulation of the neuronal pathway from the prelimbic cortex (PrL) to the paraventricular nucleus of the thalamus (PVT) decreases the incentive value of a reward-cue. In contrast, in goal-trackers, inhibition of the PrL-PVT pathway increases both the incentive value and dopamine levels in the nucleus accumbens shell. The PrL-PVT pathway, therefore, exerts top-down control over the dopamine-dependent process of incentive salience attribution. These results highlight PrL-PVT pathway as a potential target for treating psychopathologies associated with the attribution of excessive incentive value to reward-cues, including addiction.

Indexed as

Behavior, AnimalCuesAnimalsLimbic SystemMotivationNeural PathwaysRatsRewarddopamineincentive salienceneurosciencenucleus accumbensparaventricular nucleus of the thalamusprelimbic cortexratsign-tracking

Identifiers

PMID31502538
PMCPMC6739869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.